Suzanne L. Wolden

17.9k total citations
348 papers, 11.4k citations indexed

About

Suzanne L. Wolden is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Suzanne L. Wolden has authored 348 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Pulmonary and Respiratory Medicine, 123 papers in Surgery and 91 papers in Oncology. Recurrent topics in Suzanne L. Wolden's work include Sarcoma Diagnosis and Treatment (108 papers), Neuroblastoma Research and Treatments (66 papers) and Head and Neck Cancer Studies (66 papers). Suzanne L. Wolden is often cited by papers focused on Sarcoma Diagnosis and Treatment (108 papers), Neuroblastoma Research and Treatments (66 papers) and Head and Neck Cancer Studies (66 papers). Suzanne L. Wolden collaborates with scholars based in United States, Canada and Netherlands. Suzanne L. Wolden's co-authors include Dennis H. Kraus, David G. Pfister, Michael J. Zeléfsky, Nancy Y. Lee, Jatin P. Shah, Michael P. LaQuaglia, Leonard H. Wexler, Brian H. Kushner, Ashok R. Shaha and Sarah S. Donaldson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Suzanne L. Wolden

330 papers receiving 11.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne L. Wolden United States 59 5.2k 3.6k 3.1k 3.1k 1.8k 348 11.4k
Robert L. Foote United States 60 3.2k 0.6× 4.0k 1.1× 2.9k 0.9× 2.7k 0.9× 1.2k 0.7× 305 11.3k
Christopher J. Schultz United States 37 3.0k 0.6× 2.4k 0.7× 3.1k 1.0× 2.0k 0.6× 1.4k 0.8× 138 8.7k
Robert J. Amdur United States 54 3.0k 0.6× 5.1k 1.4× 5.2k 1.7× 3.7k 1.2× 498 0.3× 332 10.4k
Mahmut Özsahin Switzerland 43 2.1k 0.4× 2.7k 0.7× 2.8k 0.9× 2.3k 0.7× 929 0.5× 149 6.9k
Rodney R. Million United States 57 2.8k 0.5× 5.1k 1.4× 4.4k 1.4× 4.1k 1.3× 1.6k 0.8× 248 10.4k
Dirk Rades Germany 49 4.5k 0.9× 4.4k 1.2× 895 0.3× 3.5k 1.1× 2.3k 1.2× 586 10.3k
Nancy P. Mendenhall United States 55 3.5k 0.7× 1.7k 0.5× 464 0.1× 2.8k 0.9× 2.0k 1.1× 357 8.5k
Umberto Ricardi Italy 48 4.8k 0.9× 2.3k 0.6× 606 0.2× 2.7k 0.9× 1.4k 0.8× 362 10.0k
Pamela K. Allen United States 56 7.5k 1.4× 3.9k 1.1× 486 0.2× 4.6k 1.5× 1.7k 0.9× 289 12.5k
Arnold C. Paulino United States 46 3.0k 0.6× 1.6k 0.4× 492 0.2× 1.3k 0.4× 647 0.4× 299 6.8k

Countries citing papers authored by Suzanne L. Wolden

Since Specialization
Citations

This map shows the geographic impact of Suzanne L. Wolden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne L. Wolden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne L. Wolden more than expected).

Fields of papers citing papers by Suzanne L. Wolden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne L. Wolden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne L. Wolden. The network helps show where Suzanne L. Wolden may publish in the future.

Co-authorship network of co-authors of Suzanne L. Wolden

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne L. Wolden. A scholar is included among the top collaborators of Suzanne L. Wolden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne L. Wolden. Suzanne L. Wolden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Christopher B., Wei Xue, Abha A. Gupta, et al.. (2025). Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children’s Oncology Group. International Journal of Radiation Oncology*Biology*Physics. 123(1). 54–62.
2.
Casey, Dana L., Kathryn R. Tringale, Michael P. LaQuaglia, et al.. (2024). Intraoperative radiation therapy for pediatric sarcomas and other solid tumors. Pediatric Blood & Cancer. 71(6). e30949–e30949.
3.
Luo, Leo Y., Amira Qumseya, Juan C. Vasquez, et al.. (2024). Whole Lung Irradiation in Rhabdomyosarcoma With Lung Metastases: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Journal of Clinical Oncology. 42(36). 4263–4270. 1 indexed citations
4.
Kushner, Brian H., Shakeel Modak, Michael P. LaQuaglia, et al.. (2023). Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy.. Journal of Clinical Oncology. 41(16_suppl). 10037–10037. 1 indexed citations
6.
Koyama, Tatsuki, Lili Sun, Suzanne L. Wolden, et al.. (2022). Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031. Journal of Adolescent and Young Adult Oncology. 12(3). 359–365. 3 indexed citations
7.
Yechieli, Raphael, Henry Mandeville, Susan M. Hiniker, et al.. (2021). Rhabdomyosarcoma. Pediatric Blood & Cancer. 68(S2). e28254–e28254. 19 indexed citations
8.
Aye, Jamie M., Yueh‐Yun Chi, Jing Tian, et al.. (2020). Do children and adolescents with completely resected alveolar rhabdomyosarcoma require adjuvant radiation? A report from the Children's Oncology Group. Pediatric Blood & Cancer. 67(5). e28243–e28243. 7 indexed citations
9.
Imber, Brandon S., Suzanne L. Wolden, Hilda E. Stambuk, et al.. (2019). Novel intraoperative radiotherapy utilizing prefabricated custom three-dimensionally printed high-dose-rate applicators. Brachytherapy. 18(3). 277–284. 7 indexed citations
10.
Lazarev, Stanislav, Brian H. Kushner, & Suzanne L. Wolden. (2018). Short Hypofractionated Radiation Therapy in Palliation of Pediatric Malignancies: Outcomes and Toxicities. International Journal of Radiation Oncology*Biology*Physics. 102(5). 1457–1464. 13 indexed citations
11.
Weiss, Aaron R., Elizabeth Lyden, James R. Anderson, et al.. (2013). Histologic and Clinical Characteristics Can Guide Staging Evaluations for Children and Adolescents With Rhabdomyosarcoma: A Report From the Children's Oncology Group Soft Tissue Sarcoma Committee. Journal of Clinical Oncology. 31(26). 3226–3232. 75 indexed citations
12.
La, Trang H., Suzanne L. Wolden, Zheng Su, et al.. (2010). Local Therapy for Rhabdomyosarcoma of the Hands and Feet: Is Amputation Necessary? A Report From the Children's Oncology Group. International Journal of Radiation Oncology*Biology*Physics. 80(1). 206–212. 13 indexed citations
13.
Bakst, Richard L., Nancy Lee, David G. Pfister, et al.. (2010). Hypofractionated Dose-Painting Intensity Modulated Radiation Therapy With Chemotherapy for Nasopharyngeal Carcinoma: A Prospective Trial. International Journal of Radiation Oncology*Biology*Physics. 80(1). 148–153. 74 indexed citations
14.
Setton, Jeremy, N. Caria, Jonathan Romanyshyn, et al.. (2010). Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: An Update of the Memorial Sloan-Kettering Cancer Center Experience. International Journal of Radiation Oncology*Biology*Physics. 82(1). 291–298. 136 indexed citations
15.
Rodeberg, David A., Julie A. Stoner, Andrea Hayes‐Jordan, et al.. (2009). Prognostic Significance of Tumor Response at the End of Therapy in Group III Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 27(22). 3705–3711. 47 indexed citations
16.
Kushner, Brian H., Nai‐Kong V. Cheung, Christopher A. Barker, et al.. (2009). Hyperfractionated Low-Dose (21 Gy) Radiotherapy for Cranial Skeletal Metastases in Patients With High-Risk Neuroblastoma. International Journal of Radiation Oncology*Biology*Physics. 75(4). 1181–1186. 9 indexed citations
17.
Wolden, Suzanne L., Christopher A. Barker, Brian H. Kushner, et al.. (2007). Brain‐sparing radiotherapy for neuroblastoma skull metastases. Pediatric Blood & Cancer. 50(6). 1163–1168. 10 indexed citations
18.
Puri, Dev R., Paul A. Meyers, Dennis H. Kraus, et al.. (2006). Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumors. Pediatric Blood & Cancer. 50(1). 167–169. 17 indexed citations
19.
Michalski, Jeff M., Jane L. Meza, John C. Breneman, et al.. (2004). Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. International Journal of Radiation Oncology*Biology*Physics. 59(4). 1027–1038. 69 indexed citations
20.
Wolden, Suzanne L., Smitha Gollamudi, Michael P. LaQuaglia, et al.. (2000). Local control with multimodality therapy for Stage 4 neuroblastoma. International Journal of Radiation Oncology*Biology*Physics. 46(4). 969–974. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026